Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
- 17 August 2021
- journal article
- research article
- Published by Elsevier BV in Current Opinion in Virology
- Vol. 50, 119-127
- https://doi.org/10.1016/j.coviro.2021.08.004
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil functionNature Immunology, 2017
- Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel DiseaseGastroenterology, 2017
- Innate Immune Pattern Recognition: A Cell Biological PerspectiveAnnual Review of Immunology, 2015
- Type I interferons in infectious diseaseNature Reviews Immunology, 2015
- Sepsis: Current Dogma and New PerspectivesImmunity, 2014
- Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapyNature Reviews Immunology, 2013
- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virusNature Genetics, 2013
- Climate Change, 2007Water, Air, & Soil Pollution, 2007
- IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complexNature Immunology, 2002
- IL-28, IL-29 and their class II cytokine receptor IL-28RNature Immunology, 2002